GSK plc (LON:GSK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,336.50
-9.00 (-0.67%)
Apr 17, 2025, 5:18 PM BST
GSK plc Employees
GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.
Employees
68,629
Change (1Y)
-1,583
Growth (1Y)
-2.25%
Revenue / Employee
457.18K GBP
Profits / Employee
37.52K GBP
Market Cap
54.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,315 |
| Genus | 3,500 |
GSK plc News
- 1 day ago - UK approves combination therapies of GSK's blood cancer drug Blenrep - Reuters
- 2 days ago - Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease - GlobeNewsWire
- 2 days ago - AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices - Business Wire
- 2 days ago - GSK’s meningococcal vaccine gets positive recommendation from ACIP - Seeking Alpha
- 2 days ago - GSK's 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices - Business Wire
- 3 days ago - GSK is misleading prescription information on Omjjara, PMCPA says - Seeking Alpha
- 4 days ago - GSK in breach for misleading prescribing information on Omjjara, industry body says - Reuters
- 4 days ago - Goldman cites a “positive surprise” for GSK ahead of ACIP meeting on RSV shot - Seeking Alpha